University of Münster
CRIS@UM
DE | EN

Dr. rer. nat. Jan Sperveslage

No current affiliations available for this person. The person is no longer active at the university.

Publications

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
Kemper M; Evers G; Schulze AB; Sperveslage J; Schülke C; Lenz G; Herold T; Hartmann W; Schildhaus HU; Bleckmann A (2022)
In: Oncotarget, 13, 1216-1216. doi:10.18632/oncotarget.28293
Research article (journal) | Peer reviewed | Published
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A (2021)
In: Oncotarget, 12(19), 1946-1952. doi:10.18632/oncotarget.28062
Research article (journal) | Peer reviewed | Published
Gastrointestinale Stromatumoren des Magens und ihre Vorstufen
Wardelmann E, Hartmann W, Trautmann M, Sperveslage J, Elges S, Hekeler E, Huss S (2017)
In: Der Pathologe, 38(2), 105-111. doi:10.1007/s00292-017-0275-z
Research article (journal) | Peer reviewed | Published
Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
Stock K, Steinestel K, Wiesch R, Mikesch J, Hansmeier A, Trautmann M, Beller N, Rehkämper J, Wardelmann E, Heitkötter B (2017)
In: BioMed Research International, 2017. doi:10.1155/2017/2847303
Research article (journal) | Peer reviewed | Published